• Users Online: 271
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2021  |  Volume : 9  |  Issue : 2  |  Page : 94-99

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and updates in bethesda system for thyroid fine-needle aspiration cytology: An overview


Pathology and Laboratory Medicine, Karkinos Healthcare, Kerala, India

Correspondence Address:
Dr. Ajit Nambiar
Director, Pathology and Laboratory Medicine, 3rd Floor, JLN Stadium Metrostation, Kaloor, Kochi 682017, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jhnps.jhnps_66_21

Rights and Permissions

Thyroid cancer incidence rising in the community has been a matter of concern. The possibility of a certain category of papillary carcinoma, namely the encapsulated follicular variant contributing to this rise needed a thorough look in. Scientific evidence has led to this category to be taken out from the malignant categorization even though the entity has the presence of the typical papillary nuclei. A new well-defined indolent category of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has been defined with both inclusion and exclusion criteria. This has led to some disruption in the risk of malignancy assessments in the Bethesda system of thyroid fine-needle aspiration cytology. Importantly, cytology is limited in distinguishing the invasive from encapsulated follicular variants of papillary thyroid carcinomas. The new Bethesda system provides for a descriptive footnote in the category 4–6 on the need to consider the indolent counterpart NIFTP. Furthermore, category 3, atypia of undetermined significance (AUS)/follicular lesion of undetermined significance is well defined with an explanation for the reason behind using this terminology as this is a heterogeneous category. The NIFTP group is associated with RAS mutations unlike the BRAF mutations in the classical papillary carcinomas.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1071    
    Printed40    
    Emailed0    
    PDF Downloaded71    
    Comments [Add]    

Recommend this journal